Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.5450 (-0.53%) ($7.5450 - $7.5450) on Wed. Dec. 23, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.31% (three month average) | RSI | 78 | Latest Price | $7.5450(-0.53%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.8% a day on average for past five trading days. | Weekly Trend | BCRX advances 8.2% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(43%) IBB(38%) IWO(37%) IWC(36%) IWM(36%) | Factors Impacting BCRX price | BCRX will decline at least -2.655% in a week (0% probabilities). VIXM(-19%) UUP(-13%) VXX(-8%) IGOV(-4%) EDOC(-3%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.655% (StdDev 5.31%) | Hourly BBV | -0.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.02(-5.92%) | 10 Day Moving Average | $8.09(-6.74%) | 20 Day Moving Average | $7.04(7.17%) | To recent high | -11.5% | To recent low | 49.9% | Market Cap | $1.331b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |